BioCentury | Feb 24, 2021
Deals

Feb. 23 Quick Takes: BGI raises $300M, plus a $230M C round for Clover, Day One, Waksal’s Graviton, Asalyxa

...by GL Ventures and Temasek. New investors Oceanpine Capital and OrbiMed Advisors and existing investor Delos Capital...
BioCentury | Dec 31, 2020
Finance

Dec. 30 Quick Takes: Transcenta leads year-end crop of China venture rounds

...disease company Eccogene (Shanghai) Co. Ltd. raised RMB100 million in an undisclosed round co-led by Delos Capital...
BioCentury | Apr 11, 2020
Emerging Company Profile

Clover: trimerizing fusion proteins

...of employees: Over 200 Funds raised: Over $110 million Investors: Tianhe Life Sciences Venture Fund, Delos Capital...
BioCentury | Dec 3, 2019
Financial News

Dec. 2 Financial Quick Takes: Kodiak gains on royalty deal; plus Clover, Aslan, Transcenta, EOC, Hui-Gene and ViGeneron

...capital raised by the Chengdu-based cancer and autoimmune company to over $100 million since 2016. Delos Capital...
BioCentury | Sep 23, 2019
Financial News

Sept. 23 Financial Quick Takes: Innate looks to add U.S. listing; plus Curamir's launch, Qihan Bio and Vedanta

...Underwriters are Citigroup, SVB Leerink and Evercore. Delos launches Watson's Curamir with $10M A round Delos Capital...
BioCentury | Jun 5, 2019
Financial News

Oncolytic virus play OncoMyx raises $25M series A

...A round to develop its oncolytic virus programs in solid cancers. Boehringer Ingelheim Venture Fund, Delos Capital...
BioCentury | Nov 30, 2018
Financial News

Pharmasset, Idenix vets lead HBV company Antios to $25M series A

...Ventures and Domain Associates led the oversubscribed series A round. Other investors included CAM Capital, Delos Capital...
BioCentury | Nov 27, 2018
Financial News

Pharmasset, Idenix vets lead HBV company Antios to $25M series A

...Ventures and Domain Associates led the oversubscribed series A round. Other investors included CAM Capital, Delos Capital...
BioCentury | Jul 13, 2017
Financial News

LipoSeuticals completes venture financing

...29 that it raised undisclosed funds in a “recently closed” series A round led by Delos Capital...
BioCentury | Jun 20, 2016
Financial News

Allecra completes venture financing

...Germany Business: Infectious Date completed: 2016-06-15 Type: Venture financing Raised: EUR22 million ($24.8 million) Investors: Delos Capital...
Items per page:
1 - 10 of 13
BioCentury | Feb 24, 2021
Deals

Feb. 23 Quick Takes: BGI raises $300M, plus a $230M C round for Clover, Day One, Waksal’s Graviton, Asalyxa

...by GL Ventures and Temasek. New investors Oceanpine Capital and OrbiMed Advisors and existing investor Delos Capital...
BioCentury | Dec 31, 2020
Finance

Dec. 30 Quick Takes: Transcenta leads year-end crop of China venture rounds

...disease company Eccogene (Shanghai) Co. Ltd. raised RMB100 million in an undisclosed round co-led by Delos Capital...
BioCentury | Apr 11, 2020
Emerging Company Profile

Clover: trimerizing fusion proteins

...of employees: Over 200 Funds raised: Over $110 million Investors: Tianhe Life Sciences Venture Fund, Delos Capital...
BioCentury | Dec 3, 2019
Financial News

Dec. 2 Financial Quick Takes: Kodiak gains on royalty deal; plus Clover, Aslan, Transcenta, EOC, Hui-Gene and ViGeneron

...capital raised by the Chengdu-based cancer and autoimmune company to over $100 million since 2016. Delos Capital...
BioCentury | Sep 23, 2019
Financial News

Sept. 23 Financial Quick Takes: Innate looks to add U.S. listing; plus Curamir's launch, Qihan Bio and Vedanta

...Underwriters are Citigroup, SVB Leerink and Evercore. Delos launches Watson's Curamir with $10M A round Delos Capital...
BioCentury | Jun 5, 2019
Financial News

Oncolytic virus play OncoMyx raises $25M series A

...A round to develop its oncolytic virus programs in solid cancers. Boehringer Ingelheim Venture Fund, Delos Capital...
BioCentury | Nov 30, 2018
Financial News

Pharmasset, Idenix vets lead HBV company Antios to $25M series A

...Ventures and Domain Associates led the oversubscribed series A round. Other investors included CAM Capital, Delos Capital...
BioCentury | Nov 27, 2018
Financial News

Pharmasset, Idenix vets lead HBV company Antios to $25M series A

...Ventures and Domain Associates led the oversubscribed series A round. Other investors included CAM Capital, Delos Capital...
BioCentury | Jul 13, 2017
Financial News

LipoSeuticals completes venture financing

...29 that it raised undisclosed funds in a “recently closed” series A round led by Delos Capital...
BioCentury | Jun 20, 2016
Financial News

Allecra completes venture financing

...Germany Business: Infectious Date completed: 2016-06-15 Type: Venture financing Raised: EUR22 million ($24.8 million) Investors: Delos Capital...
Items per page:
1 - 10 of 13